Not a high-falutin' Pee Aich Dee economist. Just a lowly physician tryin' to make sense of these Interesting Times. "The State is the great fiction through which everyone endeavours to live at the expense of everyone else." Frederic Bastiat, 1848 I am but a bemused and conjurepated skeptic in a world of majestic deceptions.
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) firstname.lastname@example.org.
I'm a CFA Charterholder and hold an MBA in Finance.
I spend a large amount of my free time analyzing and investing in energy companies of varying size. I'm currently covering oil and gas producers in the Permian Basin and the Eagle Ford. I try to provide quarterly coverage for several companies. I also look at oil and gas producers globally, in search of strong value plays. Anytime I find one, I write about it.
I will do my absolute best to provide quality research for you to consider in your investment decisions. However, I suggest you consult with your financial advisor prior to taking any action after reading an article, comment, private chat, or any other communication that I wrote. I urge you do your own research and draw your own conclusions prior to taking any action. My articles or comments are your starting point for your research. After you enter a trade, you are on your own to enter, exit, or take no action on the trade. I am not liable for actions you take after reading something that I wrote.
Elliott Gue knows energy. Since earning his bachelor’s and master’s degrees from the University of London, Elliott has dedicated himself to learning the ins and outs of this dynamic sector, scouring trade magazines, attending industry conferences, touring facilities and meeting with management teams.
For seven years, Elliott Gue shared his expertise and stock-picking abilities with individual investors through a highly regarded, energy-focused research publication. Elliott Gue’s knowledge of the sector and prescient investment calls prompted the official program of the 2008 G-8 Summit in Tokyo to call him “the world’s leading energy strategist.”
He has also appeared on CNBC and Bloomberg TV and has been quoted in a number of major publications, including Barron’s, Forbes and the Washington Post.
In October 2012, Elliott Gue launched the Energy & Income Advisor (www.EnergyandIncomeAdvisor.com), a semimonthly online newsletter that’s dedicated to uncovering the most profitable opportunities in the energy sector, from growth stocks to high-yielding utilities, royalty trusts and master limited partnerships.
The masthead may have changed, but subscribers can expect the same in-depth analysis and rational assessments of investment opportunities in the energy sector.
My interaction, collaboration with and assessment of different biotech companies in the past 10+ years gives me a unique insight into their dynamics, goals, struggles, competitive arenas, and their likelihood to succeed. Therefore, my articles are based on hands-on experience and don’t rely merely on research of available written material out there in the cloud.
I have studied during the last 20+ years intensively lethal virological and bacteriological pathogens and gained experience in rational vaccine design and the approval process for human and veterinarian vaccine candidates.
I have been involved in many aspects of the biotechnology field (university, government, biotechnology companies) ranging from Basic Research and Development, Project/Program Management, Teaching, Business Development, Process Development, Manufacturing, Quality Assurance and Quality Control, Clinical Development, and Regulatory Affairs.
Biotech, specifically start-up or early stage companies are high-risk investments, but with the right pick, proper due diligence and some luck a fantastic return can be achieved. In addition, due diligence gives a potential investor insight into potential world-changing therapeutics and prophylactic measures urgently needed in our health care system.
Chief Investment Officer, Stanford Wealth Management. Retired senior exec of Charles Schwab. 36 years active and reserve military service -- 6 in special operations, 30 in the intelligence community. Geopolitical analyst.
Author -- investment book Bringing Home the Gold.
Editor -- The Investor’s Edge®. In the 16 years from inception through year-end 2015, the Investor’s Edge® Growth & Value Portfolio increased in value from $250,000 to $1,038,453. That same $250,000 invested in the S&P 500 rose to just $422,905. (Past results are no guarantee of future performance; maybe those 16 years were pure luck.)
Featured in Forbes, Barrons, The Wall Street Journal, Financial World, Wall Street Transcript, Global Investing, Welling on Wall Street, etc.
If you have a $500,000 portfolio ($250,000 for solely mutual funds & ETFs) you may contact me for a no-obligation "second opinion." email@example.com.
Personal/private investor. I've followed Axion from JP's altenergystocks.com days. Previously involved in what, over time, became known as the garment wet processing business - prewashing, stonewashing, acidwashng, dyeing, and other value-add processes for major garment manufacturers, and eventually offering goods cut and sewn to our specs for national and regional distribution.
Subsequently, traveled as a professional photographer (fashion, editorial and fine art) though in recent years family duties require staying in place. So, now its watching the market with related interest in macro influences to the market.
I obtained my CPA in 1990 and became a CFA charter holder in 2000. I consider myself an expert in Quantitative and Qualitative analysis and have extensive experience in Technical Analysis. I also have a deep interest in stock market history and hold degrees in Economics (BSBA) and Management Information Systems (MBA). I have been actively involved with investment analysis and investment management since 1985 but have been a student of investing since the 1960s. I owned my first individual stock position while still in high school. I am a student of Benjamin Graham and Warren Buffett. I have achieved a uniquely diverse experience from multiple careers that has allowed me to develop a broad perspective enabling me to look at the big picture of macroeconomics all the way down to the retail unit or factory floor. In my youth I was in retail, then served in reconnaissance during my tours in Vietnam. I have been a blue collar, union worker in a factory and a manager in services, hospitality and transportation as well as a manager of professional staffs. I have more than 20 years of experience each in both public and private sectors. I have personal points of reference that many analysts will never have. I bring more to the table than just the theories and models I have studied or built. To understand more about my investing philosophy please visit my blog on my website.
I am teaching and doing research in mathematics at University Paris 12. I have a PhD in Dynamical Systems from the University of Orsay.My main hobbies are investing, programming, playing pool, parenting and playing backgammon.I am co-founder of a startup which helps institutions digitize and organize paper documents. We hope to complete an OCR software developed in house that will allow indexing scanned books.
Equipment Operator, Journeyman Lineman (IBEW), Programmer, Systems Analyst, Network Engineer, IT Director, Owner/Operator for Alliant Tech Systems, Ensign Brickford Aerospace, General Dynamics, General Electric (various braches), Global Nuclear, Hewlett-Packard, High Test Labs, Intel, L3 Communications, Lockheed Martin, Raytheon, Spectra Technologies, Trident Refit Facilities, United Launch Alliance, Vestas, Westinghouse.
I am now a Licensed Massage Therapist (LMT) in the state of Oregon. Need a massage?
I'm a full time, long time Private Investor in under the radar high risk/reward stocks. I have also been a Portfolio Manager of a large fixed income and equities portfolio, Investment Advisor, Financial Consultant, and a Financial Analyst. Degree in Finance.
I have been investing in the stock market as a personal investor for approximately ten years now. I began my training in an accelerated pre-med program, and have continued both my interest and research in related topics. I only invest in companies after very lengthy deliberation, although am apt to leave the market entirely for periods of time. I have almost exclusively traded in the biotech sector.
I am a seasoned entrepreneurial adventurer and am doomed to learn something new every day. I have been advising laypeople about investments since I was in high school. I'm suspicious about the self-proclaimed "experts" in the industry, making investment decisions for myself and advising others through due diligence analysis, logical decision processes and top down allocation methodology.
I spent 40 years designing and providing the administration for pension and medical plans for jointly negotiated- labor and management trust funds as the CEO of the trusts with investment management, due diligence, policy development and oversight responsibilities.
I give back some by helping folks structure their assets to enable them to sleep better at night and develop plans for the future.
Over 25 years individual investment experience in stocks, bonds, options, and Forex trading. I have developed my own model to find out of favor stocks, stocks with high short interest, and developing technologies for high value investment opportunities.
Bachelor of Arts, Criminal Justice: Homeland Security
10 yr Navy Veteran
Stanford University Tech Trades Manager
I am an individual investor with 10 years of investing experience but no professional investing experience. I have avidly followed companies and stocks for over 15 years but have really only considered writing about stocks recently. I have an engineering degree and currently work in upper level sales management in computers. My investing focus is on small companies, especially biotechnology firms, as I believe these are areas which are not as well covered by existing financial outlets enabling outsized gains if these companies are researched properly.
I'm 32, invest in the light of the Austrian economic tradition, which in today's environment means mostly precious metals and mining stocks using cycles and sentiment as timing mechanisms. ETF's, options, I also own some physical. I've been doing this independently for 3 years. I reserve a small chunk of my portfolio for speculating in biotech and technology where I believe appropriate.
Mike Holt is a Senior VP, Wealth Management Strategist with The MDE Group, an innovative Wealth Management Firm located in Morristown, NJ that manages over $1 billion for corporate executives and other high net worth individuals located across the US. Mike's diverse background includes auditing financial services firms in NY for a Big 4 CPA firm, a 3-year foreign assignment to Saudi Arabia during which he also travelled extensively, primarily in Europe, Africa, the Middle East, and Asia, and the provision of sophisticated income and estate tax services to partners, directors, and executives at ARAMCO, KKR, Citibank, Lloyds, Lehman Brothers, McKinsey & Co., and Pfizer among others.
He is also a CFP and a PFS, and since 1994 he has been helping clients of The MDE Group to accumulate wealth, and then to preserve that wealth against the backdrop of an increasingly uncertain economic and market environment. Mike's dedication to his clients has driven him to draw upon his broad experience and intense curiosity about the world to investigate global macro risks that have become increasingly relevant to both the successful management of their portfolios and, more importantly, their overall financial well being and that of their families.
Mike earned a Bachelor of Science in Business Administration from Cal State, Long Beach and participated in the MS Taxation program at Pace University in New York.
Please note that the views I express in my posts and comments do not always reflect the views of The MDE Group.
PhD in Molecular Biology, Manchester University, UK. 14 years in biomedical research with a decade in R&D for Japanese pharma focused on Alzheimer's disease. Specialised in genomics, authoring several patent applications.
Moved domicile from the UK to France. Away from bench research and into IT but still passionate about science.
Author of "3000 Days of Dementia" - an uncompromising view of the Alzheimer's research community.
I'm a value investor focused on buying companies trading below the intrinsic value.
I've a back ground in engineering & finance. I'm also a Chartered Financial Analyst. I did my MBA from Emory University's Goizueta School of Business
I worked in New York's financial sector for almost exactly 20 years, mostly as a healthcare analyst (drugs, biotech, and medical devices), but also as an assistant research director, portfolio manager, and options strategist. My last formal job had me in charge of Value Line's premium priced "Select" and "Special Situation" products. The former highlights the company's top stock pick of each month and the latter introduces relatively small companies. I quit that job in June, 2009 for reasons that a dozen or so confidentiality agreements preclude my discussing. In September of that year, I launched 3DimensionalResearch.com (3DR), which allows me to continue doing what I was doing previously.
I am a strong believer in maximum transparency, in both personal and business relationships. So, in that vein:
A google search will show that my former employer sued 3DR and me in November, 2009 for copyright infringement, hot news misappropriations, and the proverbial kitchen sink. Although a search won't show this, unfortunately, I represented myself in a federal courtroom in December and, in accordance with the judge's instructions, the case was settled in a matter of minutes.
Additional Disclosure: 3DR has been a financial failure thus far, in terms of getting subscribers. I detest marketing and few people want to pay for information anymore, least of all from a no-name website. That said, the vast majority of my recommendations have done very well and my personal portfolio is doing extraordinarily well (65.5% in 2013) since I tend to follow most of my own recommendations, the "event driven special situations," in particular.
I like exposing Penny Stock Pump and Dumps. Most of my research is done to help good hard working people avoid being scammed into investing in a pump and dump. Share the reports to show Seeking Alpha they are worth publishing this kind of information to help people avoid losing money in pump and dumps.